rosiglitazone has been researched along with bromodeoxyuridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auwerx, J; Egler, V; Fajas, L; Lefebvre, AM; Miard, S; Reiter, R | 1 |
| Cho, JH; Choi, JH; Hwang, IK; Lee, CH; Moon, JB; Park, OK; Sohn, Y; Won, MH; Yoo, KY | 1 |
| Bernd, A; Kaufmann, R; Kippenberger, S; Müller, J; Ochsendorf, F; Schuster, M; Thaçi, D; Zouboulis, CC | 1 |
| Alfaro-Cervello, C; Cortes-Canteli, M; Garcia-Verdugo, JM; Luna-Medina, R; Morales-Garcia, JA; Perez-Castillo, A; Santos, A | 1 |
| Liang, XJ; Meng, QQ; Shen, HY; Wang, P; Wang, XP; Wu, YF; Yang, JW | 1 |
5 other study(ies) available for rosiglitazone and bromodeoxyuridine
| Article | Year |
|---|---|
PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner.
Topics: 3T3 Cells; Adipocytes; Animals; Apoptosis; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Flow Cytometry; G1 Phase; G2 Phase; Gene Expression Regulation; Histone Deacetylases; In Situ Nick-End Labeling; Luciferases; Mice; Microscopy, Fluorescence; Mitosis; Neoplasms; Plasmids; Precipitin Tests; Receptors, Cytoplasmic and Nuclear; Retinoblastoma Protein; RNA, Small Interfering; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 2003 |
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, decreases immunoreactivity of markers for cell proliferation and neuronal differentiation in the mouse hippocampus.
Topics: Animals; Biomarkers; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Glial Cell Line-Derived Neurotrophic Factor; Hypoglycemic Agents; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Inbred ICR; Microtubule-Associated Proteins; Neurons; Neuropeptides; PPAR gamma; Rosiglitazone; Stem Cells; Thiazolidinediones | 2010 |
Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?
Topics: Acne Vulgaris; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Line; Enzyme Inhibitors; Humans; L-Lactate Dehydrogenase; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; PPAR alpha; PPAR delta; PPAR gamma; Pyrimidines; Rosiglitazone; Sebaceous Glands; Staurosporine; Thiazolidinediones | 2011 |
Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adult Stem Cells; Animals; Bromodeoxyuridine; Caspase 3; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cerebral Ventricles; Doublecortin Domain Proteins; Glial Fibrillary Acidic Protein; Male; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Neural Cell Adhesion Molecule L1; Neural Stem Cells; Neuropeptides; Olfactory Bulb; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Sialic Acids; Thiazolidinediones | 2011 |
Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Nuclear; Antimetabolites; Blood-Brain Barrier; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Female; Flow Cytometry; Inflammation; Intermediate Filament Proteins; Movement; Nerve Tissue Proteins; Nestin; Neural Stem Cells; NF-kappa B; PPAR gamma; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones | 2011 |